Beijing Balance Medical Technology Co.,Ltd.

SHSE:688198 Rapporto sulle azioni

Cap. di mercato: CN¥16.4b

Beijing Balance Medical TechnologyLtd Crescita futura

Future criteri di controllo 5/6

Beijing Balance Medical TechnologyLtd is forecast to grow earnings and revenue by 41.1% and 34.6% per annum respectively. EPS is expected to grow by 40.8% per annum. Return on equity is forecast to be 19.6% in 3 years.

Informazioni chiave

41.1%

Tasso di crescita degli utili

40.8%

Tasso di crescita dell'EPS

Medical Equipment crescita degli utili27.5%
Tasso di crescita dei ricavi34.6%
Rendimento futuro del capitale proprio19.6%
Copertura analitica

Low

Ultimo aggiornamento23 Sep 2024

Aggiornamenti recenti sulla crescita futura

Nessun aggiornamento

Recent updates

Beijing Balance Medical Technology Co.,Ltd.'s (SHSE:688198) 42% Jump Shows Its Popularity With Investors

Oct 09
Beijing Balance Medical Technology Co.,Ltd.'s (SHSE:688198) 42% Jump Shows Its Popularity With Investors

Beijing Balance Medical TechnologyLtd (SHSE:688198) Strong Profits May Be Masking Some Underlying Issues

Aug 28
Beijing Balance Medical TechnologyLtd (SHSE:688198) Strong Profits May Be Masking Some Underlying Issues

Beijing Balance Medical Technology Co.,Ltd. (SHSE:688198) Not Flying Under The Radar

Jul 03
Beijing Balance Medical Technology Co.,Ltd. (SHSE:688198) Not Flying Under The Radar

If EPS Growth Is Important To You, Beijing Balance Medical TechnologyLtd (SHSE:688198) Presents An Opportunity

Jun 04
If EPS Growth Is Important To You, Beijing Balance Medical TechnologyLtd (SHSE:688198) Presents An Opportunity

The Consensus EPS Estimates For Beijing Balance Medical Technology Co.,Ltd. (SHSE:688198) Just Fell A Lot

May 10
The Consensus EPS Estimates For Beijing Balance Medical Technology Co.,Ltd. (SHSE:688198) Just Fell A Lot

The Returns On Capital At Beijing Balance Medical TechnologyLtd (SHSE:688198) Don't Inspire Confidence

Apr 11
The Returns On Capital At Beijing Balance Medical TechnologyLtd (SHSE:688198) Don't Inspire Confidence

Previsioni di crescita degli utili e dei ricavi

SHSE:688198 - Stime future degli analisti e dati finanziari passati (CNY Millions )
DataRicaviGuadagniFlusso di cassa liberoLiquidità dell'operazioneAvg. Numero di analisti
12/31/2026923301N/A2671
12/31/2025692220N/A1771
12/31/2024513161N/A1261
9/30/2024406104-11357N/A
6/30/2024394106-6562N/A
3/31/2024382112-23112N/A
12/31/202337111513141N/A
9/30/202333210610137N/A
6/30/202332210221152N/A
3/31/202329493-11125N/A
12/31/20222959524129N/A
9/30/20222897125116N/A
6/30/20222686222103N/A
3/31/2022266564286N/A
12/31/202125251476N/A
9/30/2021246521478N/A
6/30/2021240502173N/A
3/31/2021211561162N/A
12/31/2020182574351N/A
9/30/2020158604248N/A
6/30/2020144644850N/A
3/31/2020138595355N/A
12/31/2019146636264N/A
9/30/2019136445660N/A
12/31/2018111335254N/A
12/31/20179242N/A46N/A
12/31/20167831N/A45N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: 688198's forecast earnings growth (41.1% per year) is above the savings rate (2.9%).

Guadagni vs Mercato: 688198's earnings (41.1% per year) are forecast to grow faster than the CN market (25.8% per year).

Guadagni ad alta crescita: 688198's earnings are expected to grow significantly over the next 3 years.

Ricavi vs Mercato: 688198's revenue (34.6% per year) is forecast to grow faster than the CN market (14% per year).

Ricavi ad alta crescita: 688198's revenue (34.6% per year) is forecast to grow faster than 20% per year.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: 688198's Return on Equity is forecast to be low in 3 years time (19.6%).

Scoprire le aziende in crescita

7D

1Y

7D

1Y

7D

1Y